Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients

February 24, 2022
Business Services

NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …

News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022
Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …

News

Extra blood test could help detect risk of death from heart attack

February 23, 2022
Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …

News

FDA places gene therapy trial on hold

February 23, 2022
Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …

News

NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types

February 23, 2022
Research and Development

NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …

News

FDA grants approval for expanded indication of heart failure sensor

February 22, 2022
Manufacturing and Production

The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …

News

NovoBiome and Inserm begin collaboration into human intestinal physiology

February 22, 2022
Manufacturing and Production

NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …

News

UK to offer extra COVID-19 booster for over-75s and high risk in spring

February 22, 2022
Manufacturing and Production

An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …

News

Apollo Therapeutics and King’s College London collaborate for translational biology and drug development

February 22, 2022
Manufacturing and Production

Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …

News

CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China

February 21, 2022
Sales and Marketing

CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …

News

FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia

February 21, 2022
Sales and Marketing

Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …

News

‘Historic’ results for breast cancer drug and promise for broader use

February 21, 2022
Sales and Marketing

AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …

News

FDA considers approving second COVID-19 booster jab

February 21, 2022
Sales and Marketing

US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …

News

Study shows antibiotics affect gut microbes of newborns

February 18, 2022
Medical Communications

Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …

News

Pfizer and BioNTech Omicron vaccine delayed

February 18, 2022
Medical Communications

The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …

News

NHS bosses call for free COVID-19 tests and isolation to remain

February 18, 2022
Medical Communications

NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …

News

Trial paused for respiratory virus vaccine in pregnant women

February 18, 2022
Medical Communications

GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …

News

FDA accepts NDA for non-small cell lung cancer treatment

February 17, 2022
Business Services

Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …

News

England to offer COVID-19 vaccine to five to 11-year-olds

February 17, 2022
Business Services

Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …

News

First Promising Innovative Medicine designation for self-administered treatment of rare disease

February 17, 2022
Business Services

UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026